Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Expert Opinion on Therapeutic Patents|February 24, 2011
Cathepsin S inhibitors: 2004-2010Alice Lee-Dutra, Danielle K Wiener, Siquan SunBioorganic & Medicinal Chemistry Letters|March 2, 2010
Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitorsDanielle K Wiener, Alice Lee-Dutra, Scott Bembenek, et al.Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regionsJohn J M Wiener, Alvah T Wickboldt, Danielle K Wiener, et al.Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors: part 1Alice Lee-Dutra, Danielle K Wiener, Kristen L Arienti, et al.Frontiers in Pharmacology|April 9, 2015
7α, 25-dihydroxycholesterol-mediated activation of EBI2 in immune regulation and diseasesSiquan Sun, Changlu LiuCurrent Topics in Medicinal Chemistry|March 27, 2010
Recent advances in the design of cathepsin S inhibitorsJohn J M Wiener, Siquan Sun, Robin L ThurmondCurrent Opinion in Investigational Drugs (London, England : 2000)|May 26, 2005
Cathepsin S inhibitors as novel immunomodulatorsRobin L Thurmond, Siquan Sun, Lars Karlsson, et al.Inflammation & Allergy Drug Targets|January 29, 2008
TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disordersSiquan Sun, Navin L Rao, Jennifer Venable, et al.Bioorganic & Medicinal Chemistry Letters|September 24, 2016
Fluoro analogs of bioactive oxy-sterols: Synthesis of an EBI2 agonist with enhanced metabolic stabilityXiaohu Deng, Siquan Sun, Jiejun Wu, et al.Bioorganic & Medicinal Chemistry Letters|October 17, 2007
2-Aryl benzimidazoles featuring alkyl-linked pendant alcohols and amines as inhibitors of checkpoint kinase Chk2Danielle K Neff, Alice Lee-Dutra, Jonathan M Blevitt, et al.Pageof 4